OCTOBEr 2021

GLOBE NEWSWIRE

Kronos Bio, Inc. , a company dedicated to transforming the lives of those affected by cancer, recently announced that it will present preclinical data in a poster at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics.

BusinessWorld

Merck announced recently a supply and purchase agreement that will provide Singapore with access to its experimental oral COVID–19 antiviral drug, the latest Asian country to try to snap up supplies.
Molnupiravir is designed to introduce errors into the genetic code of the virus and would be the first oral antiviral medication for COVID–19. Merck is seeking approval by the United States Food and Drug Administration for the pill.

CosmeticsDesign-Asia

The rise of ‘wanghong’ beauty influencers in China and growing interest for functional and customised cosmetics have been revealed as some of the changing purchasing habits post-COVID-19.

Global Cosmetics News

Shiseido’s new research facility ‘Shiseido China Innovation Center Shanghai Fengxian Branch’ has commenced its activities. The facility will focus on developing cutting-edge cosmetics technologies and utility evaluation methods, as well as exploring new beauty fields beyond cosmetics. In collaboration with key universities, research will focus on utility evaluation method research institutes, cosmetics OEM manufacturers, and ingredient/fragrance/packaging manufacturers.

Global Cosmetics News

The Chinese National Medical Products Administration has announced that it is cracking down on sales of counterfeit cosmetics, according to a report published by Reuters. The regulator is planning to toughen its stance on unsubstantiated medical claims made on cosmetics packaging as well as pull unregistered products from shelves.

GLOBE NEWSWIRE

Sensus Healthcare, Inc. a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that the Chinese Health Authority has renewed Sensus’ license to market the SRT-100™ system in Greater China for an additional five years.

Manila Bulletin

Total medical product manufacturing investments in the country’s economic zones have reached P21.8 billion, but robust growth is expected following keen interest from world’s pharmaceutical companies, including Pakistanis, to expand operations in the Philippines.